Category: Next-generation therapies
Calyx Welcomes Catalyst to the ACTIVATE CRO Partnership Program Synergistic offerings deliver successful early phase oncology clinical trials Nottingham, UK – May 10, 2021 Read Now
Webinar: Clinical Trial Flexibility and Customization Needs that Are Required by Biotechs and Next-generation Therapies COVID-19 has ushered in new challenges when conducting clinical trials, but mid-tier biotech companies have Read Now